Increased incidence of brain metastases in ERCC1-negative NSCLC patients treated with adjuvant cisplatin-based chemotherapy

被引：0
|
作者：
Besse, B.
Massard, C.
Haddad, V.
Andre, F.
Dunant, A.
Pirker, R.
Olaussen, K. A.
Brambilla, E.
Fouret, P.
Soria, J.
机构：
[1] Inst Gustave Roussy, Villejuif, France
[2] Med Univ Vienna, Vienna, Austria
[3] Ctr Hosp Univ Albert Michallon, Grenoble, France
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
7581
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer
    Le Chevalier, T
    Arriagada, R
    Le Péchoux, C
    Grunenwald, D
    Dunant, A
    Pignon, JP
    Tarayre, M
    Abratt, R
    Arriagada, R
    Bergman, B
    Gralla, R
    Grunenwald, D
    Le Chevalier, T
    Orlowski, T
    Papadakis, E
    Pinel, MIS
    Araujo, C
    Della Torre, H
    de Solchaga, MM
    Abdi, E
    Blum, R
    Ball, D
    Basser, R
    De Boer, R
    Bishop, J
    Brigham, B
    Davis, S
    Fox, D
    Richardson, G
    Wyld, D
    Pirker, R
    Humblet, Y
    Delaunois, L
    Van Meerbeeck, JP
    Germonpre, P
    Vansteenkiste, J
    Nackaerts, K
    Pinel, MIS
    Vauthier, G
    Younes, RN
    Arriagada, R
    Baeza, R
    Carvajal, P
    Kleinman, S
    Orlandi, L
    Castro, C
    Godoy, J
    Kosatova, K
    Gaafar, R
    Azarian, R
    NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (04): : 351 - 360
  • [42] Excision repair cross-complementation group 1 (ERCC1) expression in advanced urothelial carcinoma patients receiving cisplatin-based chemotherapy
    Kim, Kyoung Ha
    Do, In-Gu
    Kim, Hyeong Su
    Chang, Myung Hee
    Kim, Hyo Song
    Jun, Hyun Jung
    Uhm, Jieun
    Yi, Seong Yoon
    Lim, Do Hyoung
    Ji, Sang Hoon
    Park, Min Jae
    Lee, Jeeyun
    Park, Se Hoon
    Kwon, Ghee Young
    Lim, Ho Yeong
    APMIS, 2010, 118 (12) : 941 - 948
  • [43] Prognostic model for overall survival in patients with metastatic urothelial cancer treated with cisplatin-based chemotherapy
    Galsky, Matt D.
    Krege, Susanne
    Lin, Chia-Chi
    Hahn, Noah M.
    Ecke, Thorsten
    Moshier, Erin L.
    Sonpavde, Guru
    Godbold, James H.
    Oh, William K.
    Bamias, Aristotelis
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [44] Prognostic factors for survival in patients with advanced oesophageal cancer treated with cisplatin-based combination chemotherapy
    M B Polee
    W C J Hop
    T C Kok
    F A L M Eskens
    M E L van der Burg
    T A W Splinter
    P D Siersema
    H W Tilanus
    G Stoter
    A van der Gaast
    British Journal of Cancer, 2003, 89 : 2045 - 2050
  • [45] Prognostic Model for Predicting Survival of Patients With Metastatic Urothelial Cancer Treated With Cisplatin-Based Chemotherapy
    Apolo, Andrea B.
    Ostrovnaya, Irina
    Halabi, Susan
    Iasonos, Alexia
    Philips, George K.
    Rosenberg, Jonathan E.
    Riches, Jamie
    Small, Eric J.
    Milowsky, Matthew I.
    Bajorin, Dean F.
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2013, 105 (07): : 499 - 503
  • [46] Outcome of elderly patients with recurrent or metastatic head and neck cancer treated with cisplatin-based chemotherapy
    Argiris, A
    Li, Y
    Murphy, BA
    Langer, CJ
    Forastiere, AA
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (02) : 262 - 268
  • [47] Prognostic factors for survival in patients with advanced oesophageal cancer treated with cisplatin-based combination chemotherapy
    Polee, MB
    Hop, WCJ
    Kok, TC
    Eskens, FALM
    van der Burg, MEL
    Splinter, TAW
    Siersema, PD
    Tillanus, HW
    Stoter, G
    van der Gaast, A
    BRITISH JOURNAL OF CANCER, 2003, 89 (11) : 2045 - 2050
  • [48] ERCC1 AND BETA-TUBULIN III IN ADVANCED NSCLC PATIENTS TREATED WITH CISPLATIN-VINORELBINE
    de Castro, G., Jr.
    Victor, C. R.
    Bigaton, F. J.
    Takahashi, T. K.
    Feher, O.
    Saber, A. M. Ab'
    Takagaki, T. Y.
    Siqueira, S. A. C.
    Chammas, R.
    Hoff, P. M. G.
    JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (06) : S33 - S34
  • [49] BRAIN METASTASES - A PHARMACOLOGICAL SANCTUARY - RESPONSE OF BRAIN METASTASES IN BREAST-CANCER PATIENTS TREATED WITH PRIOR ADJUVANT OR PALLIATIVE CHEMOTHERAPY
    ROSNER, D
    NEMOTO, T
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1987, 28 : 444 - 444
  • [50] Polymorphisms in ERCC1 C8092A predict progression-free survival in metastatic/recurrent nasopharyngeal carcinoma treated with cisplatin-based chemotherapy
    Cui Chen
    Fenghua Wang
    Zhiqiang Wang
    Cong Li
    Huiyan Luo
    Ying Liang
    Xin An
    Jianyong Shao
    Yuhong Li
    Cancer Chemotherapy and Pharmacology, 2013, 72 : 315 - 322
12345